Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF)

1,2100 0,0000 (0,00 %) À la clôture : 02:22PM EDT

Shanghai Pharmaceuticals Holding Co., Ltd

Shanghai Pharmaceutical Building
No. 200 Taicang Road
Shanghai 200020
China
86 21 6373 0908
https://www.sphchina.com

Secteur(s): Healthcare
Secteur d’activité: Medical Distribution
Employés à temps plein: 48 164

Dirigeants clés

Nom	Titre	Payer	Exercé	Année de naissance
Mr. Qiuhua Yang	Executive Chairman	S.O.	S.O.	1972
Mr. Bo Shen	President, CFO, Head of the Accounting Department & Executive Director	778,93k	S.O.	1973
Mr. Yongzhong Li	VP & Executive Director	832,67k	S.O.	1970
Mr. Ming Dong	Executive Director	S.O.	S.O.	1976
Mr. Tao Zhong	VP, Board Secretary & Joint Company Secretary	S.O.	S.O.	1972
Mr. Dongming Li	Vice President	S.O.	S.O.	1969
Ms. Shuai Shao	Vice President	S.O.	S.O.	1988
Dr. Shunjiang Yu	Chief Medical Officer	S.O.	S.O.	S.O.
Ms. Pui Kiu Wong	Joint Company Secretary	S.O.	S.O.	S.O.
Ying Ke	Director & General Manager of R&D Management Center	S.O.	S.O.	S.O.

Les montants ont été établis en date du 31 décembre 2023 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Shanghai Pharmaceuticals Holding Co., Ltd. engages research, development, manufacture, distribution, and retailing of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including digestive system, immune metabolism, motor neuron disease, endocrinology, cardiovascular, psychoneurotic, neoplasm, autoimmunity, systemic anti-infection, mental nerve, anti-tumor, oncology, respiratory system, nervous system, auto-immunity, hypertension, neuromyelitis, diabetes, anticholinesterase, polypeptide hormones uterine tonic, antihistamine, anti-inflammatory, anesthetic, immunomodulatory, antiviral, reflux esophagitis, analgesics, weight management, malignant peritoneal effusion, ulcerative colitis, myasthenia gravis, burn injury, anticoagulant, anti-epileptic, anticonvulsant, Alzheimer's, and inflammatory bowel diseases. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores. The company was incorporated in 1994 and is headquartered in Shanghai, China.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Shanghai Pharmaceuticals Holding Co., Ltd en date du 1 avril 2024 est 8. Les scores principaux sont Audit : 7; Société : 10; Droits des actionnaires : 9; Compensation : 2.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.